IL1β- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease

Neurogastroenterology and Motility

Volumn 21, Issue 4, 2009, Pages 439-450

  Kidd, M ^a   Gustafsson, B I ^a   Drozdov, I ^a   Modlin, I M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's; Enterochromaffin cell; IL1 ; Lipopolysaccharide; Serotonin

Indexed keywords

ANGIOPEPTIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; SEROTONIN; SOMATOSTATIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENTEROCHROMAFFIN CELL; ENZYME PHOSPHORYLATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEROTONIN RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; SIGNAL TRANSDUCTION;

CROHN DISEASE; ENTEROCHROMAFFIN CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 62449290353     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01210.x     Document Type: Article

References (72)

1. Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Curr Opin Investig Drugs 2004 5 : 55 60.
2. Thompson A, Keelman M, Thiesen A, Clandinin M, Ropeleski M, Wild G. Small bowel review: normal physiology part 2. Dig Dis Sci 2001 46 : 2588 607.
3. Yang GB, Lackner AA. Proximity between 5-HT secreting enteroendocrine cells and lymphocytes in the gut mucosa of rhesus macaques (Macaca mulatta) is suggestive of a role for enterochromaffin cell 5-HT in mucosal immunity. J Neuroimmunol 2004 146 : 46 9.
4. + T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut 2007 56 : 949 57.
5. Leon-Ponte M, Ahern GP, O'Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 2007 109 : 3139 46.
6. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002 347 : 417 29.
7. Gershon M. Review article: Serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004 20 (Suppl. 7 3 14.
8. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005 17 : 863 70.
9. Linden D, Foley K, McQuoid C, Simpson J, Sharkey K, Mawe G. Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol Motil 2005 17 : 565 74.
10. Kyosola K, Penttila O, Salaspuro M. Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol 1977 12 : 363 7.
11. El-Salhy M, Danielsson A, Stenling R, Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 1997 242 : 413 9.
12. Belai A, Boulos PB, Robson T, Burnstock G. Neurochemical coding in the small intestine of patients with Crohn's disease. Gut 1997 40 : 767 74.
13. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998 22 : 382 9.
14. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995 154 : 2434 40.
15. Minderhoud IM, Oldenburg B, Schipper ME, Ter Linde JJ, Samsom M. Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission. Clin Gastroenterol Hepatol 2007 5 : 714 20.
16. Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 2005 11 : 580 8.
17. Fort MM, Mozaffarian A, Stover AG et al. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 2005 174 : 6416 23.
18. Reubi JC, Mazzucchelli L, Laissue JA. Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology 1994 106 : 951 9.
19. Watanabe T, Kubota Y, Sawada T, Muto T. Distribution and quantification of somatostatin in inflammatory disease. Dis Colon Rectum 1992 35 : 488 94.
20. Kidd M, Modlin I, Eick G, Champaneria M. Isolation, purification and functional characterization of the Mastomys EC cell. Am J Physiol 2006 291 : G778 91.
21. Modlin IM, Kidd M, Eick G, Champaneria M. The functional characterization of normal and neoplastic EC cells. J Clin Endocrinol Metab 2006 91 : 2340 8.
22. Stevens C, Walz G, Singaram C et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992 37 : 818 26.
23. Gross V, Andus T, Leser HG, Roth M, Scholmerich J. Inflammatory mediators in chronic inflammatory bowel diseases. Klin Wochenschr 1991 69 : 981 7.
24. Fiocchi C, Hilfiker ML, Youngman KR, Doerder NC, Finke JH. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 1984 86 : 734 42.
25. Reinecker HC, Steffen M, Witthoeft T et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993 94 : 174 81.
26. Breese EJ, Michie CA, Nicholls SW et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994 106 : 1455 66.
27. Reimund JM, Wittersheim C, Dumont S et al. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996 39 : 684 9.
28. Raab Y, Gerdin B, Ahlstedt S, Hallgren R. Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 1993 34 : 1203 6.
29. Cominelli F, Pizarro TT. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment Pharmacol Ther 1996 10 (Suppl. 2 49 53. discussion 54.
30. Dionne S, D'Agata ID, Hiscott J, Vanounou T, Seidman EG. Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol 1998 112 : 435 42.
31. Mitsuyama K, Sasaki E, Toyonaga A et al. Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion 1991 50 : 104 11.
32. Waidmann M, Bechtold O, Frick JS et al. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 2003 125 : 162 77.
33. Kim SC, Tonkonogy SL, Albright CA et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005 128 : 891 906.
34. Dunne A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003 2003 : re3.
35. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007 7 : 179 90.
36. Kidd M, Nadler B, Mane SM et al. GeneChip, geNorm and Gastrointestinal tumors: novel reference genes for real-time PCR. Physiol Genomics 2007 30 : 363 70.
37. Kidd M, Miu K, Tang LH et al. Helicobacter pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin-like cells. Gastroenterology 1997 113 : 1110 7.
38. Grider JR. Interleukin-1 beta selectively increases substance P release and augments the ascending phase of the peristaltic reflex. Neurogastroenterol Motil 2003 15 : 607 15.
39. Kidd M, Modlin I, Gustafsson B, Drozdov I, Hauso O, Pfragner R. The luminal regulation of normal and neoplastic EC cell serotonin release is mediated by bile salts, amines, tastants and olfactants. Am J Physiol 2008 295 : G260 72.
40. Sjolund K, Sanden G, Hakanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983 85 : 1120 30.
41. Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine 2003 20 : 255 64.
42. Coughlin SR, Moskowitz MA, Antoniades HN, Levine L. Serotonin receptor-mediated stimulation of bovine smooth muscle cell prostacyclin synthesis and its modulation by platelet-derived growth factor. Proc Natl Acad Sci USA 1981 78 : 7134 8.
43. Buchheit KH, Engel G, Mutschler E, Richardson B. Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms. Naunyn Schmiedebergs Arch Pharmacol 1985 329 : 36 41.
44. Siriwardena A, Kellum JM Jr. A 5-HT2 receptor mediates serotonin-induced electrolyte transport in rat left colon. J Surg Res 1993 55 : 323 9.
45. Bobker DH, Williams JT. Serotonin-mediated inhibitory postsynaptic potential in guinea-pig prepositus hypoglossi and feedback inhibition by serotonin. J Physiol 1990 422 : 447 62.
46. Alvarado-Alvarez R, Arechiga H, Garcia U. Serotonin activates a Ca(2+)-dependent K(+) current in identified peptidergic neurons from the crayfish. J Exp Biol 2000 203 : 715 23.
47. Sidhu M, Cooke HJ. Role for 5-HT and ACh in submucosal reflexes mediating colonic secretion. Am J Physiol 1995 269 : G346 51.
48. Cooke HJ, Wang YZ, Frieling T, Wood JD. Neural 5-hydroxytryptamine receptors regulate chloride secretion in guinea pig distal colon. Am J Physiol 1991 261 : G833 40.
49. Kidd M, Eick GN, Modlin IM, Pfragner R, Champaneria MC, Murren J. Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin. J Mol Endocrinol 2007 38 : 181 92.
50. Kitaoka Y, Munemasa Y, Nakazawa T, Ueno S. NMDA-induced interleukin-1beta expression is mediated by nuclear factor-kappa B p65 in the retina. Brain Res 2007 1142 : 247 55.
51. Lomax AE, Linden DR, Mawe GM, Sharkey KA. Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits. Auton Neurosci 2006 127 : 250 7.
52. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 2000 6 : 205 14.
53. Pastor Rojo O, Lopez San Roman A, Albeniz Arbizu E, de la Hera Martinez A, Ripoll Sevillano E, Albillos Martinez A. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis 2007 13 : 269 77.
54. Dionne S, Laberge S, Deslandres C, Seidman EG. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease. Clin Exp Immunol 2003 133 : 108 14.
55. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000 68 : 7010 7.
56. Franchimont D, Vermeire S, El Housni H et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004 53 : 987 92.
57. Oostenbrug LE, Drenth JP, de Jong DJ et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 2005 11 : 567 75.
58. Gazouli M, Mantzaris G, Kotsinas A et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005 11 : 681 5.
59. Sandborn W, Targan S. Biologic therapy of inflammatory bowel disease. Gastroenterology 2002 122 : 1592 608.
60. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut 1990 31 : 686 9.
61. Prinz C, Neumayer N, Mahr S, Classen M, Schepp W. Functional impairment of rat enterochromaffin-like cells by interleukin 1 beta. Gastroenterology 1997 112 : 364 75.
62. Doyle SL, O'Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 2006 72 : 1102 13.
63. Jang HJ, Kokrashvili Z, Theodorakis MJ et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 2007 104 : 15069 74.
64. Koch TR, Carney JA, Morris VA, Go VL. Somatostatin in the idiopathic inflammatory bowel diseases. Dis Colon Rectum 1988 31 : 198 203.
65. Eliakim R, Karmeli F, Rachmilewitz D. Decreased somatostatin (SS) generation by colonic mucosa in active ulcerative colitis. Gastroenterology 1991 100 : A578.
66. Eliakim R, Karmeli F, Okon E, Rachmilewitz D. Octreotide effectively decreases mucosal damage in experimental colitis. Gut 1993 34 : 264 9.
67. Redmann A, Rasch A, Tourne H, Mann K, Petersenn S. Characterization and transcriptional regulation of the human somatostatin receptor subtype 1 gene. Horm Metab Res 2007 39 : 359 65.
68. Baumeister H, Meyerhof W. Gene regulation of somatostatin receptors in rats. J Physiol Paris 2000 94 : 167 77.
69. Hofland LJ, van Hagen PM, Lamberts SW. Functional role of somatostatin receptors in neuroendocrine and immune cells. Ann Med 1999 31 (Suppl. 2 23 7.
70. van Bergeijk JD, Wilson JH, Nielsen OH et al. Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1). Eur J Gastroenterol Hepatol 2002 14 : 243 8.
71. van der Hoek J, van der Lelij AJ, Feelders RA et al. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients. Clin Endocrinol (Oxf) 2005 63 : 176 84.
72. Nilsson AH. The gut as the largest endocrine organ in the body. Ann Oncol 2001 12 (Suppl. 2 S63 8.